Enhanced antitumor activity mediated by human 4-1BB-engineered T cells.

Area of Science:

• Immunology
• Cancer Biology
• Genetic Engineering

Background:

• The 4-1BB/4-1BBL pathway is crucial for CD8(+) T-cell responses and survival.
• 4-1BBL is expressed on antigen-presenting cells and tumor cells, suggesting a role in anti-tumor immunity.

Purpose of the Study:

• To investigate the relevance of the 4-1BB/4-1BBL pathway in genetically modified human T cells.
• To assess the impact of constitutive 4-1BB expression on T-cell anti-melanoma activity.

Main Methods:

• Human T cells from healthy donors and melanoma patients were transduced to constitutively express 4-1BB.
• Co-culture of modified T cells with melanoma tumor lines.
• Assessment of T-cell activation, cytotoxicity, proliferation, survival, and response to immunosuppression.

Main Results:

• 4-1BB-transduced T cells showed enhanced cytokine secretion, activation marker upregulation, and increased cytotoxicity against melanoma.
• Modified T cells exhibited higher proliferation rates, increased Bcl-XL expression, and relative insensitivity to TGF-β immunosuppression.
• Target cell 4-1BBL expression was essential for 4-1BB-mediated functional improvements.

Conclusions:

• Genetic modification of human T cells to express 4-1BB significantly enhances their anti-tumor function.
• This approach holds potential for immunotherapies involving genetically modified patient lymphocytes for cancer treatment.